scholarly journals Meniere Disease: A Case Report

2021 ◽  
Vol 2 (5) ◽  
Author(s):  
Edfina Rahmarini ◽  
Hanik Badriyah Hidayati
Keyword(s):  
Hearing Loss ◽  
Meniere’S Disease ◽  
Pharmacological Therapy ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Episodic Vertigo ◽  
Ménière's Disease ◽  
Fluctuating Hearing Loss

Background: Meniere’s disease is a clinical disorder defined as the idiopathic syndrome of endolymphatic hydrops. Meniere’s disease has a prevalence of about 200 cases per 100,000 people in the United States. Prevalence increases linearly with increasing age, especially over 60 years. Men and women are estimated to be proportional in the number of cases. The etiology of Meniere’s disease is currently known to be caused by intrinsic factors and extrinsic factors. Symptoms of Meniere’s disease include recurrent spontaneous episodic vertigo, fluctuating hearing loss, ear fullness, and tinnitus. Treatment of Meniere’s disease can be divided into pharmacological therapy and non-pharmacological therapy. In some cases, complaints can be reduced to 80-90 percent. Case Report: A woman, aged 65 years, complained of constant ringing in her right ear, feeling full and accompanied by decreased hearing in the right ear, spinning dizziness that is not related to changing position, especially when she is tired, ringing in the ear, a feeling of fullness in the ear since 3 months ago. Head MRI results were normal. The patient was treated with HCT 1×50 mg, prednisone 1×80 mg for 7 days, KSR 3×1 tablet, betahistine 2×24 mg. Patients experience improvement in complaints even though the complaints do not disappear completely Conclusion: The diagnosis of Meniere’s disease is established by clinical symptoms, namely recurrent spontaneous episodic vertigo, fluctuating hearing loss, ear fullness, and tinnitus. Appropriate therapy in Meniere’s disease can reduce complaints and improve the patient’s quality of life.

Fluctuating hearing loss in West African and West Indian racial groups: yaws, syphilis or Menière's disease?

1982 ◽  
Vol 96 (9) ◽  
pp. 847-855 ◽  
Author(s):  
R. J. Black ◽  
W. P. R. Gibson ◽  
J. W. R. Capper
Keyword(s):  
Hearing Loss ◽  
Meniere’S Disease ◽  
West African ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Racial Groups ◽  
Menière's Disease ◽  
Ménière's Disease ◽  
Fluctuating Hearing Loss

Four cases of fluctuating hearing loss in West African and West Indian racial groups are presented. Two are Menière's disease, and the authors are unaware of any report in English publications describing Menière's disease in these racial groups. One is late syphilitic hearing loss and the other is idiopathic. The possible role of yaws is presented and long-held beliefs questioned.

scholarly journals Problems and Solutions for Fitting Amplification to Patients with Ménière's Disease

2006 ◽  
Vol 17 (01) ◽  
pp. 006-015 ◽  
Author(s):  
Michael Valente ◽  
Karen Mispagel ◽  
Maureen L. Valente ◽  
Timothy Hullar
Keyword(s):  
Hearing Loss ◽  
Speech Recognition ◽  
Hearing Aid ◽  
Meniere’S Disease ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Menière's Disease ◽  
Ménière's Disease ◽  
Fluctuating Hearing Loss

Fitting amplification to a patient with Ménière's disease (MD) can present several challenges to the dispensing audiologist. These challenges include the presence of fluctuating hearing loss, a rising audiometric configuration, unilateral or asymmetrical hearing loss, reduced dynamic range, and reduced word-recognition scores. The presence of any one of these characteristics could create obstacles for a successful hearing aid fit. The presence of most if not all of these characteristics in a single patient can readily challenge the skills of even the most experienced dispensing audiologist. In addition to the audiometric challenges, this patient population has the added psychological problems associated with feeling ill due to the nausea secondary to vertiginous attacks and the anxiety associated with the unpredictable nature of the course of these attacks. This paper summarizes numerous strategies and technologies that could be implemented by the audiologist to address these unique challenges and provide a greater opportunity for a successful hearing aid fit. These suggestions include (1) advantages offered by digital signal processing; (2) using directional microphones and assistive listening devices to improve speech recognition in noise; (3) using wireless hearing aids as well as the bone anchored hearing aid; (4) counseling patients on the realistic expectations from amplification in noisy listening situations and for those with poor speech recognition; (5) using multiple programs for patients with fluctuating hearing loss; and (6) offering suggestions on programming the frequency-gain/output response for a rising configuration.

scholarly journals Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière’s Disease

2018 ◽  
Vol 2018 ◽  
pp. 1-11 ◽  
Author(s):  
Augusto Pietro Casani ◽  
Elena Navari ◽  
Giorgio Guidetti ◽  
Michel Lacour
Keyword(s):  
Hearing Loss ◽  
Meniere’S Disease ◽  
Consensus Conference ◽  
Menière’S Disease ◽  
Meniere's Disease ◽  
Ménière’S Disease ◽  
Clinical Approach ◽  
Menière's Disease ◽  
Delphi Consensus ◽  
Ménière's Disease

Menière’s disease is a disorder of the inner ear that causes vertigo, tinnitus, fullness, and hearing loss. Several pharmacological treatments are available, but none of them has shown significant results. Betahistine has been largely used but its effect on the main symptoms of Menière’s disease remains unclear. In order to improve clinical appropriateness and to reduce the heterogeneity of the therapeutic approaches for Menière’s disease, we proposed a European Consensus Conference on Betahistine’s prescription. A group of European experts in vestibular disorders completed a questionnaire, prepared by opinion leaders, on the use of betahistine in Menière’s disease. The Delphi method was used as an iterative investigation method in order to increase and establish the consensus. While betahistine was considered useful to reduce the number of the vertigo attacks during the intercritical phase of the disease, its use during attacks was considered helpful only when associated with other drugs. Betahistine was not considered useful for preventing hearing loss. The experts support the use of betahistine during the intercritical phase of the disease to reduce the number and severity of vertigo episodes. They also defined the parameters for a good clinical approach to evaluate the efficacy of betahistine treatment for Menière’s disease.

Sign in / Sign up

Export Citation Format

Share Document